Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back

Evdokia Anagnostou, MD (she/her/hers)

Vice President of Research
Bloorview Research institute
Toronto, Ontario, Canada

Presentation(s):

  • Phase 2 Clinical Trials of Arbaclofen for Autism: Canadian and EU Studies in Youth 5-17 Years Old and Pooled Meta-Analysis

    Saturday, May 4, 2024
    11:45 AM – 12:00 PM ET

    Disclosure(s): anavex (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Cell EI (Ongoing) (Products/Services: Consultant); Impell (Ongoing) (Products/Services: Consultant); Maplight (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Ono pharma (Ongoing) (Products/Services: Consultant); Quadrant (Ongoing) (Products/Services: Consultant); Roche (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator)

  • Co-creating Impactful Research with Community Partners

    Sunday, May 5, 2024
    8:55 AM – 9:05 AM ET

    Disclosure(s): anavex (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Cell EI (Ongoing) (Products/Services: Consultant); Impell (Ongoing) (Products/Services: Consultant); Maplight (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Ono pharma (Ongoing) (Products/Services: Consultant); Quadrant (Ongoing) (Products/Services: Consultant); Roche (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator)